Clinical Trial Update: Short Versus Long Antiplatelet Therapy After TAVI [Phase 3]

View source ↗

Summary

This clinical trial update notes a Phase 3 study evaluating short versus long antiplatelet therapy after transcatheter aortic valve replacement, which is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Snippet

Sponsor: University Hospital, Caen | Conditions: Transcatheter Aortic Valve Replacement | Phase 3 | Status: RECRUITING